ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global OTC Transdermal Analgesic Patches Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-31F14110
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global OTC Transdermal Analgesic Patches Market Research Report 2023
BUY CHAPTERS

Global OTC Transdermal Analgesic Patches Market Research Report 2025

Code: QYRE-Auto-31F14110
Report
May 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
TEVA
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Laboratoires Genevrier
BLUE-EMU
IBSA Group
Pfizer Inc
Performance Health
Actavis
TEIKOKU SEIYAKU
Novartis
Mylan NV
Hisamitsu

OTC Transdermal Analgesic Patches Market

The global market for OTC Transdermal Analgesic Patches was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for OTC Transdermal Analgesic Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Transdermal Analgesic Patches.
The OTC Transdermal Analgesic Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Transdermal Analgesic Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Transdermal Analgesic Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of OTC Transdermal Analgesic Patches Market Report

Report Metric Details
Report Name OTC Transdermal Analgesic Patches Market
Segment by Type
  • Lidocaine Patches
  • Diclofenac Patches
  • Indomethacin Patches
  • Counter-Irritant Patches
  • Others
Segment by Application
  • Pharmacy
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hisamitsu, Mylan, Johnson & Johnson, Teva, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, GSK, Haw Par, Nichiban, Laboratoires Genevrier, BLUE-EMU, IBSA Group, Pfizer, Performance Health, Actavis, Teikoku Seiyaku, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of OTC Transdermal Analgesic Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of OTC Transdermal Analgesic Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the OTC Transdermal Analgesic Patches Market report?

Ans: The main players in the OTC Transdermal Analgesic Patches Market are Hisamitsu, Mylan, Johnson & Johnson, Teva, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, GSK, Haw Par, Nichiban, Laboratoires Genevrier, BLUE-EMU, IBSA Group, Pfizer, Performance Health, Actavis, Teikoku Seiyaku, Novartis

What are the Application segmentation covered in the OTC Transdermal Analgesic Patches Market report?

Ans: The Applications covered in the OTC Transdermal Analgesic Patches Market report are Pharmacy, Clinic, Others

What are the Type segmentation covered in the OTC Transdermal Analgesic Patches Market report?

Ans: The Types covered in the OTC Transdermal Analgesic Patches Market report are Lidocaine Patches, Diclofenac Patches, Indomethacin Patches, Counter-Irritant Patches, Others

1 OTC Transdermal Analgesic Patches Market Overview
1.1 Product Definition
1.2 OTC Transdermal Analgesic Patches by Type
1.2.1 Global OTC Transdermal Analgesic Patches Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lidocaine Patches
1.2.3 Diclofenac Patches
1.2.4 Indomethacin Patches
1.2.5 Counter-Irritant Patches
1.2.6 Others
1.3 OTC Transdermal Analgesic Patches by Application
1.3.1 Global OTC Transdermal Analgesic Patches Market Value by Application (2024 VS 2031)
1.3.2 Pharmacy
1.3.3 Clinic
1.3.4 Others
1.4 Global OTC Transdermal Analgesic Patches Market Size Estimates and Forecasts
1.4.1 Global OTC Transdermal Analgesic Patches Revenue 2020-2031
1.4.2 Global OTC Transdermal Analgesic Patches Sales 2020-2031
1.4.3 Global OTC Transdermal Analgesic Patches Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 OTC Transdermal Analgesic Patches Market Competition by Manufacturers
2.1 Global OTC Transdermal Analgesic Patches Sales Market Share by Manufacturers (2020-2025)
2.2 Global OTC Transdermal Analgesic Patches Revenue Market Share by Manufacturers (2020-2025)
2.3 Global OTC Transdermal Analgesic Patches Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of OTC Transdermal Analgesic Patches, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OTC Transdermal Analgesic Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Transdermal Analgesic Patches, Product Type & Application
2.7 Global Key Manufacturers of OTC Transdermal Analgesic Patches, Date of Enter into This Industry
2.8 Global OTC Transdermal Analgesic Patches Market Competitive Situation and Trends
2.8.1 Global OTC Transdermal Analgesic Patches Market Concentration Rate
2.8.2 The Global 5 and 10 Largest OTC Transdermal Analgesic Patches Players Market Share by Revenue
2.8.3 Global OTC Transdermal Analgesic Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global OTC Transdermal Analgesic Patches Market Scenario by Region
3.1 Global OTC Transdermal Analgesic Patches Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global OTC Transdermal Analgesic Patches Sales by Region: 2020-2031
3.2.1 Global OTC Transdermal Analgesic Patches Sales by Region: 2020-2025
3.2.2 Global OTC Transdermal Analgesic Patches Sales by Region: 2026-2031
3.3 Global OTC Transdermal Analgesic Patches Revenue by Region: 2020-2031
3.3.1 Global OTC Transdermal Analgesic Patches Revenue by Region: 2020-2025
3.3.2 Global OTC Transdermal Analgesic Patches Revenue by Region: 2026-2031
3.4 North America OTC Transdermal Analgesic Patches Market Facts & Figures by Country
3.4.1 North America OTC Transdermal Analgesic Patches Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America OTC Transdermal Analgesic Patches Sales by Country (2020-2031)
3.4.3 North America OTC Transdermal Analgesic Patches Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Transdermal Analgesic Patches Market Facts & Figures by Country
3.5.1 Europe OTC Transdermal Analgesic Patches Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe OTC Transdermal Analgesic Patches Sales by Country (2020-2031)
3.5.3 Europe OTC Transdermal Analgesic Patches Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Transdermal Analgesic Patches Market Facts & Figures by Region
3.6.1 Asia Pacific OTC Transdermal Analgesic Patches Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific OTC Transdermal Analgesic Patches Sales by Region (2020-2031)
3.6.3 Asia Pacific OTC Transdermal Analgesic Patches Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America OTC Transdermal Analgesic Patches Market Facts & Figures by Country
3.7.1 Latin America OTC Transdermal Analgesic Patches Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America OTC Transdermal Analgesic Patches Sales by Country (2020-2031)
3.7.3 Latin America OTC Transdermal Analgesic Patches Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Transdermal Analgesic Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Transdermal Analgesic Patches Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa OTC Transdermal Analgesic Patches Sales by Country (2020-2031)
3.8.3 Middle East and Africa OTC Transdermal Analgesic Patches Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Transdermal Analgesic Patches Sales by Type (2020-2031)
4.1.1 Global OTC Transdermal Analgesic Patches Sales by Type (2020-2025)
4.1.2 Global OTC Transdermal Analgesic Patches Sales by Type (2026-2031)
4.1.3 Global OTC Transdermal Analgesic Patches Sales Market Share by Type (2020-2031)
4.2 Global OTC Transdermal Analgesic Patches Revenue by Type (2020-2031)
4.2.1 Global OTC Transdermal Analgesic Patches Revenue by Type (2020-2025)
4.2.2 Global OTC Transdermal Analgesic Patches Revenue by Type (2026-2031)
4.2.3 Global OTC Transdermal Analgesic Patches Revenue Market Share by Type (2020-2031)
4.3 Global OTC Transdermal Analgesic Patches Price by Type (2020-2031)
5 Segment by Application
5.1 Global OTC Transdermal Analgesic Patches Sales by Application (2020-2031)
5.1.1 Global OTC Transdermal Analgesic Patches Sales by Application (2020-2025)
5.1.2 Global OTC Transdermal Analgesic Patches Sales by Application (2026-2031)
5.1.3 Global OTC Transdermal Analgesic Patches Sales Market Share by Application (2020-2031)
5.2 Global OTC Transdermal Analgesic Patches Revenue by Application (2020-2031)
5.2.1 Global OTC Transdermal Analgesic Patches Revenue by Application (2020-2025)
5.2.2 Global OTC Transdermal Analgesic Patches Revenue by Application (2026-2031)
5.2.3 Global OTC Transdermal Analgesic Patches Revenue Market Share by Application (2020-2031)
5.3 Global OTC Transdermal Analgesic Patches Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu
6.1.1 Hisamitsu Company Information
6.1.2 Hisamitsu Description and Business Overview
6.1.3 Hisamitsu OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu OTC Transdermal Analgesic Patches Product Portfolio
6.1.5 Hisamitsu Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Company Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan OTC Transdermal Analgesic Patches Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson OTC Transdermal Analgesic Patches Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva OTC Transdermal Analgesic Patches Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Lingrui
6.5.1 Lingrui Company Information
6.5.2 Lingrui Description and Business Overview
6.5.3 Lingrui OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lingrui OTC Transdermal Analgesic Patches Product Portfolio
6.5.5 Lingrui Recent Developments/Updates
6.6 Sanofi
6.6.1 Sanofi Company Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi OTC Transdermal Analgesic Patches Product Portfolio
6.6.5 Sanofi Recent Developments/Updates
6.7 Qizheng
6.7.1 Qizheng Company Information
6.7.2 Qizheng Description and Business Overview
6.7.3 Qizheng OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Qizheng OTC Transdermal Analgesic Patches Product Portfolio
6.7.5 Qizheng Recent Developments/Updates
6.8 Endo
6.8.1 Endo Company Information
6.8.2 Endo Description and Business Overview
6.8.3 Endo OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Endo OTC Transdermal Analgesic Patches Product Portfolio
6.8.5 Endo Recent Developments/Updates
6.9 Huarun 999
6.9.1 Huarun 999 Company Information
6.9.2 Huarun 999 Description and Business Overview
6.9.3 Huarun 999 OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Huarun 999 OTC Transdermal Analgesic Patches Product Portfolio
6.9.5 Huarun 999 Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK OTC Transdermal Analgesic Patches Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Haw Par
6.11.1 Haw Par Company Information
6.11.2 Haw Par Description and Business Overview
6.11.3 Haw Par OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Haw Par OTC Transdermal Analgesic Patches Product Portfolio
6.11.5 Haw Par Recent Developments/Updates
6.12 Nichiban
6.12.1 Nichiban Company Information
6.12.2 Nichiban Description and Business Overview
6.12.3 Nichiban OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Nichiban OTC Transdermal Analgesic Patches Product Portfolio
6.12.5 Nichiban Recent Developments/Updates
6.13 Laboratoires Genevrier
6.13.1 Laboratoires Genevrier Company Information
6.13.2 Laboratoires Genevrier Description and Business Overview
6.13.3 Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Laboratoires Genevrier OTC Transdermal Analgesic Patches Product Portfolio
6.13.5 Laboratoires Genevrier Recent Developments/Updates
6.14 BLUE-EMU
6.14.1 BLUE-EMU Company Information
6.14.2 BLUE-EMU Description and Business Overview
6.14.3 BLUE-EMU OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.14.4 BLUE-EMU OTC Transdermal Analgesic Patches Product Portfolio
6.14.5 BLUE-EMU Recent Developments/Updates
6.15 IBSA Group
6.15.1 IBSA Group Company Information
6.15.2 IBSA Group Description and Business Overview
6.15.3 IBSA Group OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.15.4 IBSA Group OTC Transdermal Analgesic Patches Product Portfolio
6.15.5 IBSA Group Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Company Information
6.16.2 Pfizer Description and Business Overview
6.16.3 Pfizer OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Pfizer OTC Transdermal Analgesic Patches Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
6.17 Performance Health
6.17.1 Performance Health Company Information
6.17.2 Performance Health Description and Business Overview
6.17.3 Performance Health OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Performance Health OTC Transdermal Analgesic Patches Product Portfolio
6.17.5 Performance Health Recent Developments/Updates
6.18 Actavis
6.18.1 Actavis Company Information
6.18.2 Actavis Description and Business Overview
6.18.3 Actavis OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Actavis OTC Transdermal Analgesic Patches Product Portfolio
6.18.5 Actavis Recent Developments/Updates
6.19 Teikoku Seiyaku
6.19.1 Teikoku Seiyaku Company Information
6.19.2 Teikoku Seiyaku Description and Business Overview
6.19.3 Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Teikoku Seiyaku OTC Transdermal Analgesic Patches Product Portfolio
6.19.5 Teikoku Seiyaku Recent Developments/Updates
6.20 Novartis
6.20.1 Novartis Company Information
6.20.2 Novartis Description and Business Overview
6.20.3 Novartis OTC Transdermal Analgesic Patches Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Novartis OTC Transdermal Analgesic Patches Product Portfolio
6.20.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Transdermal Analgesic Patches Industry Chain Analysis
7.2 OTC Transdermal Analgesic Patches Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Transdermal Analgesic Patches Production Mode & Process Analysis
7.4 OTC Transdermal Analgesic Patches Sales and Marketing
7.4.1 OTC Transdermal Analgesic Patches Sales Channels
7.4.2 OTC Transdermal Analgesic Patches Distributors
7.5 OTC Transdermal Analgesic Patches Customer Analysis
8 OTC Transdermal Analgesic Patches Market Dynamics
8.1 OTC Transdermal Analgesic Patches Industry Trends
8.2 OTC Transdermal Analgesic Patches Market Drivers
8.3 OTC Transdermal Analgesic Patches Market Challenges
8.4 OTC Transdermal Analgesic Patches Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
TEVA
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Laboratoires Genevrier
BLUE-EMU
IBSA Group
Pfizer Inc
Performance Health
Actavis
TEIKOKU SEIYAKU
Novartis
Mylan NV
Hisamitsu
List of Tables
 Table 1. Global OTC Transdermal Analgesic Patches Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global OTC Transdermal Analgesic Patches Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global OTC Transdermal Analgesic Patches Market Competitive Situation by Manufacturers in 2024
 Table 4. Global OTC Transdermal Analgesic Patches Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global OTC Transdermal Analgesic Patches Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global OTC Transdermal Analgesic Patches Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global OTC Transdermal Analgesic Patches Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market OTC Transdermal Analgesic Patches Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of OTC Transdermal Analgesic Patches, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of OTC Transdermal Analgesic Patches, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of OTC Transdermal Analgesic Patches, Product Type & Application
 Table 12. Global Key Manufacturers of OTC Transdermal Analgesic Patches, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global OTC Transdermal Analgesic Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Transdermal Analgesic Patches as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global OTC Transdermal Analgesic Patches Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global OTC Transdermal Analgesic Patches Sales by Region (2020-2025) & (K Units)
 Table 18. Global OTC Transdermal Analgesic Patches Sales Market Share by Region (2020-2025)
 Table 19. Global OTC Transdermal Analgesic Patches Sales by Region (2026-2031) & (K Units)
 Table 20. Global OTC Transdermal Analgesic Patches Sales Market Share by Region (2026-2031)
 Table 21. Global OTC Transdermal Analgesic Patches Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global OTC Transdermal Analgesic Patches Revenue Market Share by Region (2020-2025)
 Table 23. Global OTC Transdermal Analgesic Patches Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global OTC Transdermal Analgesic Patches Revenue Market Share by Region (2026-2031)
 Table 25. North America OTC Transdermal Analgesic Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America OTC Transdermal Analgesic Patches Sales by Country (2020-2025) & (K Units)
 Table 27. North America OTC Transdermal Analgesic Patches Sales by Country (2026-2031) & (K Units)
 Table 28. North America OTC Transdermal Analgesic Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America OTC Transdermal Analgesic Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe OTC Transdermal Analgesic Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe OTC Transdermal Analgesic Patches Sales by Country (2020-2025) & (K Units)
 Table 32. Europe OTC Transdermal Analgesic Patches Sales by Country (2026-2031) & (K Units)
 Table 33. Europe OTC Transdermal Analgesic Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe OTC Transdermal Analgesic Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific OTC Transdermal Analgesic Patches Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific OTC Transdermal Analgesic Patches Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific OTC Transdermal Analgesic Patches Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific OTC Transdermal Analgesic Patches Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific OTC Transdermal Analgesic Patches Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America OTC Transdermal Analgesic Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America OTC Transdermal Analgesic Patches Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America OTC Transdermal Analgesic Patches Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America OTC Transdermal Analgesic Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America OTC Transdermal Analgesic Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa OTC Transdermal Analgesic Patches Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa OTC Transdermal Analgesic Patches Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa OTC Transdermal Analgesic Patches Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa OTC Transdermal Analgesic Patches Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa OTC Transdermal Analgesic Patches Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global OTC Transdermal Analgesic Patches Sales (K Units) by Type (2020-2025)
 Table 51. Global OTC Transdermal Analgesic Patches Sales (K Units) by Type (2026-2031)
 Table 52. Global OTC Transdermal Analgesic Patches Sales Market Share by Type (2020-2025)
 Table 53. Global OTC Transdermal Analgesic Patches Sales Market Share by Type (2026-2031)
 Table 54. Global OTC Transdermal Analgesic Patches Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global OTC Transdermal Analgesic Patches Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global OTC Transdermal Analgesic Patches Revenue Market Share by Type (2020-2025)
 Table 57. Global OTC Transdermal Analgesic Patches Revenue Market Share by Type (2026-2031)
 Table 58. Global OTC Transdermal Analgesic Patches Price (US$/Unit) by Type (2020-2025)
 Table 59. Global OTC Transdermal Analgesic Patches Price (US$/Unit) by Type (2026-2031)
 Table 60. Global OTC Transdermal Analgesic Patches Sales (K Units) by Application (2020-2025)
 Table 61. Global OTC Transdermal Analgesic Patches Sales (K Units) by Application (2026-2031)
 Table 62. Global OTC Transdermal Analgesic Patches Sales Market Share by Application (2020-2025)
 Table 63. Global OTC Transdermal Analgesic Patches Sales Market Share by Application (2026-2031)
 Table 64. Global OTC Transdermal Analgesic Patches Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global OTC Transdermal Analgesic Patches Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global OTC Transdermal Analgesic Patches Revenue Market Share by Application (2020-2025)
 Table 67. Global OTC Transdermal Analgesic Patches Revenue Market Share by Application (2026-2031)
 Table 68. Global OTC Transdermal Analgesic Patches Price (US$/Unit) by Application (2020-2025)
 Table 69. Global OTC Transdermal Analgesic Patches Price (US$/Unit) by Application (2026-2031)
 Table 70. Hisamitsu Company Information
 Table 71. Hisamitsu Description and Business Overview
 Table 72. Hisamitsu OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hisamitsu OTC Transdermal Analgesic Patches Product
 Table 74. Hisamitsu Recent Developments/Updates
 Table 75. Mylan Company Information
 Table 76. Mylan Description and Business Overview
 Table 77. Mylan OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Mylan OTC Transdermal Analgesic Patches Product
 Table 79. Mylan Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson OTC Transdermal Analgesic Patches Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Teva OTC Transdermal Analgesic Patches Product
 Table 89. Teva Recent Developments/Updates
 Table 90. Lingrui Company Information
 Table 91. Lingrui Description and Business Overview
 Table 92. Lingrui OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Lingrui OTC Transdermal Analgesic Patches Product
 Table 94. Lingrui Recent Developments/Updates
 Table 95. Sanofi Company Information
 Table 96. Sanofi Description and Business Overview
 Table 97. Sanofi OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sanofi OTC Transdermal Analgesic Patches Product
 Table 99. Sanofi Recent Developments/Updates
 Table 100. Qizheng Company Information
 Table 101. Qizheng Description and Business Overview
 Table 102. Qizheng OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Qizheng OTC Transdermal Analgesic Patches Product
 Table 104. Qizheng Recent Developments/Updates
 Table 105. Endo Company Information
 Table 106. Endo Description and Business Overview
 Table 107. Endo OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Endo OTC Transdermal Analgesic Patches Product
 Table 109. Endo Recent Developments/Updates
 Table 110. Huarun 999 Company Information
 Table 111. Huarun 999 Description and Business Overview
 Table 112. Huarun 999 OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Huarun 999 OTC Transdermal Analgesic Patches Product
 Table 114. Huarun 999 Recent Developments/Updates
 Table 115. GSK Company Information
 Table 116. GSK Description and Business Overview
 Table 117. GSK OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. GSK OTC Transdermal Analgesic Patches Product
 Table 119. GSK Recent Developments/Updates
 Table 120. Haw Par Company Information
 Table 121. Haw Par Description and Business Overview
 Table 122. Haw Par OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Haw Par OTC Transdermal Analgesic Patches Product
 Table 124. Haw Par Recent Developments/Updates
 Table 125. Nichiban Company Information
 Table 126. Nichiban Description and Business Overview
 Table 127. Nichiban OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Nichiban OTC Transdermal Analgesic Patches Product
 Table 129. Nichiban Recent Developments/Updates
 Table 130. Laboratoires Genevrier Company Information
 Table 131. Laboratoires Genevrier Description and Business Overview
 Table 132. Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Laboratoires Genevrier OTC Transdermal Analgesic Patches Product
 Table 134. Laboratoires Genevrier Recent Developments/Updates
 Table 135. BLUE-EMU Company Information
 Table 136. BLUE-EMU Description and Business Overview
 Table 137. BLUE-EMU OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. BLUE-EMU OTC Transdermal Analgesic Patches Product
 Table 139. BLUE-EMU Recent Developments/Updates
 Table 140. IBSA Group Company Information
 Table 141. IBSA Group Description and Business Overview
 Table 142. IBSA Group OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. IBSA Group OTC Transdermal Analgesic Patches Product
 Table 144. IBSA Group Recent Developments/Updates
 Table 145. Pfizer Company Information
 Table 146. Pfizer Description and Business Overview
 Table 147. Pfizer OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Pfizer OTC Transdermal Analgesic Patches Product
 Table 149. Pfizer Recent Developments/Updates
 Table 150. Performance Health Company Information
 Table 151. Performance Health Description and Business Overview
 Table 152. Performance Health OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Performance Health OTC Transdermal Analgesic Patches Product
 Table 154. Performance Health Recent Developments/Updates
 Table 155. Actavis Company Information
 Table 156. Actavis Description and Business Overview
 Table 157. Actavis OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Actavis OTC Transdermal Analgesic Patches Product
 Table 159. Actavis Recent Developments/Updates
 Table 160. Teikoku Seiyaku Company Information
 Table 161. Teikoku Seiyaku Description and Business Overview
 Table 162. Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Teikoku Seiyaku OTC Transdermal Analgesic Patches Product
 Table 164. Teikoku Seiyaku Recent Developments/Updates
 Table 165. Novartis Company Information
 Table 166. Novartis Description and Business Overview
 Table 167. Novartis OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Novartis OTC Transdermal Analgesic Patches Product
 Table 169. Novartis Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. OTC Transdermal Analgesic Patches Distributors List
 Table 173. OTC Transdermal Analgesic Patches Customers List
 Table 174. OTC Transdermal Analgesic Patches Market Trends
 Table 175. OTC Transdermal Analgesic Patches Market Drivers
 Table 176. OTC Transdermal Analgesic Patches Market Challenges
 Table 177. OTC Transdermal Analgesic Patches Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of OTC Transdermal Analgesic Patches
 Figure 2. Global OTC Transdermal Analgesic Patches Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global OTC Transdermal Analgesic Patches Market Share by Type: 2024 & 2031
 Figure 4. Lidocaine Patches Product Picture
 Figure 5. Diclofenac Patches Product Picture
 Figure 6. Indomethacin Patches Product Picture
 Figure 7. Counter-Irritant Patches Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global OTC Transdermal Analgesic Patches Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global OTC Transdermal Analgesic Patches Market Share by Application: 2024 & 2031
 Figure 11. Pharmacy
 Figure 12. Clinic
 Figure 13. Others
 Figure 14. Global OTC Transdermal Analgesic Patches Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global OTC Transdermal Analgesic Patches Market Size (2020-2031) & (US$ Million)
 Figure 16. Global OTC Transdermal Analgesic Patches Sales (2020-2031) & (K Units)
 Figure 17. Global OTC Transdermal Analgesic Patches Average Price (US$/Unit) & (2020-2031)
 Figure 18. OTC Transdermal Analgesic Patches Report Years Considered
 Figure 19. OTC Transdermal Analgesic Patches Sales Share by Manufacturers in 2024
 Figure 20. Global OTC Transdermal Analgesic Patches Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest OTC Transdermal Analgesic Patches Players: Market Share by Revenue in OTC Transdermal Analgesic Patches in 2024
 Figure 22. OTC Transdermal Analgesic Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global OTC Transdermal Analgesic Patches Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America OTC Transdermal Analgesic Patches Sales Market Share by Country (2020-2031)
 Figure 25. North America OTC Transdermal Analgesic Patches Revenue Market Share by Country (2020-2031)
 Figure 26. United States OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe OTC Transdermal Analgesic Patches Sales Market Share by Country (2020-2031)
 Figure 29. Europe OTC Transdermal Analgesic Patches Revenue Market Share by Country (2020-2031)
 Figure 30. Germany OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific OTC Transdermal Analgesic Patches Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific OTC Transdermal Analgesic Patches Revenue Market Share by Region (2020-2031)
 Figure 37. China OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America OTC Transdermal Analgesic Patches Sales Market Share by Country (2020-2031)
 Figure 45. Latin America OTC Transdermal Analgesic Patches Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa OTC Transdermal Analgesic Patches Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa OTC Transdermal Analgesic Patches Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE OTC Transdermal Analgesic Patches Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of OTC Transdermal Analgesic Patches by Type (2020-2031)
 Figure 55. Global Revenue Market Share of OTC Transdermal Analgesic Patches by Type (2020-2031)
 Figure 56. Global OTC Transdermal Analgesic Patches Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of OTC Transdermal Analgesic Patches by Application (2020-2031)
 Figure 58. Global Revenue Market Share of OTC Transdermal Analgesic Patches by Application (2020-2031)
 Figure 59. Global OTC Transdermal Analgesic Patches Price (US$/Unit) by Application (2020-2031)
 Figure 60. OTC Transdermal Analgesic Patches Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Transdermal Analgesic Patch Market Research Report 2024
Global Transdermal Analgesics Market Research Report 2024
Global Transdermal Skin Patch Market Research Report 2025
Global Transdermal Transmission Patches Market Research Report 2024
Transdermal Medical Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transdermal Skin Patches Market Research Report 2024
Global Transdermal Absorption Patch Market Research Report 2025
Global Non opioid Analgesic Patch Market Research Report 2024
Transdermal Drug Delivery Formulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pain Patches Market Research Report 2024
Nicotine Transdermal Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Opioid Pain Patche Market Research Report 2024
Painless Microneedle Transdermal Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global OTC Pain Medications Market Research Report 2024
Global Absorbable Transdermal Patch Market Research Report 2024
Over the Counter OTC Analgesics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contraceptive Transdermal Patche Market Research Report 2024
Global Non opioid Pain Patches Market Research Report 2024
Global Medical Transdermal Patch Market Research Report 2025
Transdermal Nicotine Patch Market
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions